“We are delighted to welcome the Delta team into the fold. The acquisition of Delta is another step forward in Astrea Bio’s rapid expansion to support the biopharmaceutical manufacturing field,” said Terry Pizzie, CEO of Astrea Bio. “This is a highly strategic move for us, allowing us to offer a full range of industry-leading purification and separation tools.”
Geoff Parnell, Co-founder and Managing Director at Delta Precision, remarked, “We look forward to joining the Astrea Bio family, further cementing the long-standing relationship between the two companies. We are confident that our expertise in column manufacturing will complement and accelerate the Astrea Bio business and customer reach.”
This acquisition marks a significant milestone for Astrea Bioseparations and will allow the company to further accelerate new product development and rapidly bring new advances in purification and separation technology to market.
About Astrea BioseparationsAstrea Bioseparations is a leading provider of chromatography solutions for the life sciences industry. With products used in the manufacture of over 20 approved therapeutic and medical products, Astrea is trusted by scientists around the world to deliver precise, reliable results. Astrea Bio is headquartered in Cambridge, UK with manufacturing facilities at the Isle of Man, British Isles, Joliette, Quebec and Massachusetts, USA. Visit:
www.astreabioseparations.com.
About Delta Precision LtdDelta Precision Ltd is a leading manufacturer of chromatography columns, known for their precision and performance in a wide range of applications. The company has a strong reputation in the industry and a commitment to providing top-quality products and excellent customer service. Visit:
www.delta-precision.co.uk.